Skip to main content
Top
Published in: Indian Journal of Gastroenterology 1/2017

01-01-2017 | Original Article

Predictors of severe outcomes in patients with Clostridium difficile infection from a Hispanic population

Authors: Laura Paláu-Dávila, Elvira Garza-González, Eva María Gutiérrez-Delgado, Adrián Camacho-Ortiz

Published in: Indian Journal of Gastroenterology | Issue 1/2017

Login to get access

Abstract

Background

Factors associated with complicated Clostridium difficile infection (CDI) may vary among populations, and predictors of severe outcomes in CDI have not been studied in Hispanic patients. The aim of this study was to identify factors associated with a higher risk of colectomy, all-cause mortality, and CDI-associated mortality in a Hispanic population.

Methods

We performed a retrospective study of all hospitalized patients with a diagnosis of CDI between January 1, 2011 and September 30, 2015 in a 450-bed teaching hospital in Monterrey, northeast Mexico. Three main outcomes were defined: fulminant colitis with subsequent colectomy, all-cause mortality within 30 days of diagnosis, and CDI-attributable mortality.

Results

Of 261 patients with diarrhea, 176 were diagnosed with CDI. For colectomy, Charlson comorbidity index, ICU stay and mechanical ventilation prior to CDI diagnosis, days with diarrhea prior to treatment, total days of hospital stay and days after CDI diagnosis, elevated ATLAS score, days of diarrhea post CDI treatment, and treatment failure significantly predicted the necessity of surgical treatment with colectomy.

Conclusion

Treatment failure, persistent diarrhea, and a high ATLAS score were identified as risk factors for severe outcomes of CDI. A low albumin concentration and high creatinine were associated with higher overall mortality.
Literature
1.
go back to reference Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431–55.CrossRefPubMed Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431–55.CrossRefPubMed
2.
go back to reference Postma N, Kiers D, Pickkers P. The challenge of Clostridium difficile infection: overview of clinical manifestations, diagnostic tools and therapeutic options. Int J Antimicrob Agents. 2015;46 Suppl 1:S47–50.CrossRefPubMed Postma N, Kiers D, Pickkers P. The challenge of Clostridium difficile infection: overview of clinical manifestations, diagnostic tools and therapeutic options. Int J Antimicrob Agents. 2015;46 Suppl 1:S47–50.CrossRefPubMed
3.
go back to reference McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433–41.CrossRefPubMed McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433–41.CrossRefPubMed
4.
go back to reference Abou Chakra CN, McGeer A, Labbé AC, et al. Factors associated with complications of Clostridium difficile infection in a multicenter prospective cohort. Clin Infect Dis. 2015;61:1781–8.CrossRefPubMedPubMedCentral Abou Chakra CN, McGeer A, Labbé AC, et al. Factors associated with complications of Clostridium difficile infection in a multicenter prospective cohort. Clin Infect Dis. 2015;61:1781–8.CrossRefPubMedPubMedCentral
5.
go back to reference Hensgens MP, Dekkers OM, Goorhuis A, LeCessie S, Kuijper EJ. Predicting a complicated course of Clostridium difficile infection at the bedside. Clin Microbiol Infect. 2014;20:O301–8.CrossRefPubMed Hensgens MP, Dekkers OM, Goorhuis A, LeCessie S, Kuijper EJ. Predicting a complicated course of Clostridium difficile infection at the bedside. Clin Microbiol Infect. 2014;20:O301–8.CrossRefPubMed
6.
go back to reference Xu S, Huang H, Li G. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Chinese J Infect Chemother. 2011;11:426–7. Xu S, Huang H, Li G. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Chinese J Infect Chemother. 2011;11:426–7.
7.
go back to reference Miller MA, Louie T, Mullane K. Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection, which predicts response to therapy. BMC Infect Dis. 2013;13:148.CrossRefPubMedPubMedCentral Miller MA, Louie T, Mullane K. Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection, which predicts response to therapy. BMC Infect Dis. 2013;13:148.CrossRefPubMedPubMedCentral
8.
go back to reference Na X, Martin AJ, Sethi S, et al. A multi-center prospective derivation and validation of a clinical prediction tool for severe Clostridium difficile infection. PLoS One. 2015;10:e0123405.CrossRefPubMedPubMedCentral Na X, Martin AJ, Sethi S, et al. A multi-center prospective derivation and validation of a clinical prediction tool for severe Clostridium difficile infection. PLoS One. 2015;10:e0123405.CrossRefPubMedPubMedCentral
9.
go back to reference Balassiano IT, Yates EA, Domingues RM, Ferreira EO. Clostridium difficile: a problem of concern in developed countries and still a mystery in Latin America. J Med Microbiol. 2012;61:169–79.CrossRefPubMed Balassiano IT, Yates EA, Domingues RM, Ferreira EO. Clostridium difficile: a problem of concern in developed countries and still a mystery in Latin America. J Med Microbiol. 2012;61:169–79.CrossRefPubMed
10.
go back to reference Aguayo C, Flores R, Lévesque S, et al. Rapid spread of Clostridium difficile NAP1/027/ST1 in Chile confirms the emergence of the epidemic strain in Latin America. Epidemiol Infect. 2015;143:3069–73.CrossRefPubMed Aguayo C, Flores R, Lévesque S, et al. Rapid spread of Clostridium difficile NAP1/027/ST1 in Chile confirms the emergence of the epidemic strain in Latin America. Epidemiol Infect. 2015;143:3069–73.CrossRefPubMed
11.
go back to reference López-Ureña D, Quesada-Gómez C, Miranda E, Fonseca M, Rodríguez-Cavallini E. Spread of epidemic Clostridium difficile NAP1/027 in Latin America: case reports in Panama. J Med Microbiol. 2014;63:322–4.CrossRefPubMed López-Ureña D, Quesada-Gómez C, Miranda E, Fonseca M, Rodríguez-Cavallini E. Spread of epidemic Clostridium difficile NAP1/027 in Latin America: case reports in Panama. J Med Microbiol. 2014;63:322–4.CrossRefPubMed
12.
go back to reference Quesada-Gómez C, Mulvey MR, Vargas P, Gamboa-Coronado M del M, Rodríguez C, Rodríguez-Cavillini E. Isolation of a toxigenic and clinical genotype of Clostridium difficile in retail meats in Costa Rica. J Food Prot 2013;76: 348–51. Quesada-Gómez C, Mulvey MR, Vargas P, Gamboa-Coronado M del M, Rodríguez C, Rodríguez-Cavillini E. Isolation of a toxigenic and clinical genotype of Clostridium difficile in retail meats in Costa Rica. J Food Prot 2013;76: 348–51.
13.
go back to reference Camacho-Ortiz A, López-Barrera D, Hernández-García R, et al. First report of Clostridium difficile NAP1/027 in a Mexican hospital. PLoS One. 2015;10:1–10. Camacho-Ortiz A, López-Barrera D, Hernández-García R, et al. First report of Clostridium difficile NAP1/027 in a Mexican hospital. PLoS One. 2015;10:1–10.
14.
go back to reference Kim SC, Seo MY, Lee JY, et al. Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infection. Korean J Intern Med. 2016;31:125–33.CrossRefPubMed Kim SC, Seo MY, Lee JY, et al. Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infection. Korean J Intern Med. 2016;31:125–33.CrossRefPubMed
15.
go back to reference Thongprayoon C, Cheungpasitporn W, Phatharacharukul P, et al. Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes of Clostridium difficile infection: a systematic review and meta-analysis. Int J Clin Pract. 2015;69:998–1006.CrossRefPubMedPubMedCentral Thongprayoon C, Cheungpasitporn W, Phatharacharukul P, et al. Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes of Clostridium difficile infection: a systematic review and meta-analysis. Int J Clin Pract. 2015;69:998–1006.CrossRefPubMedPubMedCentral
Metadata
Title
Predictors of severe outcomes in patients with Clostridium difficile infection from a Hispanic population
Authors
Laura Paláu-Dávila
Elvira Garza-González
Eva María Gutiérrez-Delgado
Adrián Camacho-Ortiz
Publication date
01-01-2017
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 1/2017
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-016-0722-4

Other articles of this Issue 1/2017

Indian Journal of Gastroenterology 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.